Advances in the Assessment of Fibromyalgia

Rheumatic Disease Clinics of North America

Volumn 35, Issue 2, 2009, Pages 339-357

  Williams, David A ^a   Schilling, Stephen ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chronic fatigue; Co morbidities; Fibromyalgia; Pain; Questionnaire

Indexed keywords

CHRONIC DISEASE; CHRONIC PAIN; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMPUTERIZED ADAPTIVE TESTING; DEPRESSION; FATIGUE; FIBROMYALGIA; FUNCTIONAL STATUS; HUMAN; MORNING STIFFNESS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SELF REPORT; SLEEP DISORDER; TRIGGER POINT; VISUAL ANALOG SCALE;

COMORBIDITY; FATIGUE; FIBROMYALGIA; HUMANS; PAIN; QUESTIONNAIRES;

EID: 67651230704     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.05.007     Document Type: Review

References (67)

1. Wolfe F., Ross K., Anderson J., et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
2. Bennett R.M., Jones J., Turk D.C., et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8 (2007) 27-38
3. Mease P.J., Arnold L.M., Crofford L.J., et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 59 (2008) 952-960
4. Forseth K.O., and Gran J.T. Management of fibromyalgia: what are the best treatment choices?. Drugs 62 (2002) 577-592
5. Hoffman D.L., and Dukes E.M. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 62 (2008) 115-126
6. Berger A., Dukes E., Martin S., et al. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 61 (2007) 1498-1508
7. Ablin J., Neumann L., and Buskila D. Pathogenesis of fibromyalgia-a review. Joint Bone Spine 75 (2008) 273-279
8. Staud R., and Rodriguez M.E. Mechanisms of disease: pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol 2 (2006) 90-98
9. Dadabhoy D., and Clauw D.J. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 9 (2005) 399-404
10. Yoshimura M., and Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci 101 (2006) 107-117
11. Staud R., and Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr 13 (2008) 12-17
12. Mease P.J., Russell I.J., Kajdasz D.K., et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum (2009) [Epub ahead of print]
13. Arnold L.M., Russell I.J., Diri E.W., et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 9 (2008) 792-805
14. Mease P.J., Clauw D.J., Gendreau R.M., et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 36 (2009) 398-409
15. Clauw D.J., Mease P., Palmer R.H., et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30 (2008) 1988-2004
16. Goldenberg D.L., Burckhardt C., and Crofford L. Management of fibromyalgia syndrome. JAMA 292 (2004) 2388-2395
17. Smythe H.A., and Moldofsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 28 (1977) 928-931
18. Wolfe F., Smythe H.A., Yunus M.B., et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33 (1990) 160-172
19. Clauw D.J., and Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4 (1997) 134-153
20. Geisser M.E., Strader D.C., Petzke F., et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics 49 (2008) 235-242
21. Jiang Y., and Hesser J.E. Patterns of health-related quality of life and patterns associated with health risks among Rhode Island adults. Health Qual Life Outcomes 6 (2008) 1-11
22. Dominick K.L., Ahern F.M., Gold C.H., et al. Health-related quality of life and health service use among older adults with osteoarthritis. Arthritis Rheum 51 (2004) 326-331
23. Hahn E.A., Cella D., Chassany O., et al. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc 82 (2007) 1244-1254
24. Kop W.J., Lyden A., Berlin A.A., et al. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum 52 (2005) 296-303
25. Snitz B.E., Morrow L.A., Rodriguez E.G., et al. Subjective memory complaints and concurrent memory performance in older patients of primary care providers. J Int Neuropsychol Soc 14 (2008) 1004-1013
26. Unruh M.L., Redline S., An M.W., et al. Subjective and objective sleep quality and aging in the sleep heart health study. J Am Geriatr Soc 56 (2008) 1218-1227
27. Geisser M.E., Gracely R.H., Giesecke T., et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain 11 (2007) 202-207
28. Naughton M.J., and Shumaker S.A. The case for domains of function in quality of life assessment. Qual Life Res 12 Suppl 1 (2003) 73-80
29. Tugwell P., Boers M., Brooks P., et al. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8 (2007) 38
30. Arnold L.M., Crofford L.J., Mease P.J., et al. Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73 (2008) 114-120
31. Mease P.J., Clauw D.J., Arnold L.M., et al. Fibromyalgia syndrome. J Rheumatol 32 (2005) 2270-2277
32. Dworkin R.H., Turk D.C., Wyrwich K.W., et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9 (2008) 105-121
33. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75 (2005) 6-21
34. Arnold L.M., Keck P.E.J., and Welge J.A. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41 (2000) 104-113
35. Offenbacher M., Cieza A., Brockow T., et al. Are the contents of treatment outcomes in fibromyalgia trials represented in the International Classification of Functioning, Disability, and Health?. Clin J Pain 23 (2007) 691-701
36. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1 (1975) 277-299
37. Melzack R. The short-form McGill pain questionnaire. Pain 30 (1987) 191-197
38. Keller S., Bann C.M., Dodd S.L., et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 20 (2004) 309-318
39. Dworkin R.H., Turk D.C., Farrar J.T., et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113 (2005) 9-19
40. Jensen M.P., Miller L., and Fisher L.D. Assessment of pain during medical procedures: a comparison of three scales. Clin J Pain 14 (1998) 343-349
41. Jensen M.P., and McFarland C.A. Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain 55 (1993) 195-203
42. Belza B.L., Henke C.J., Yelin E.H., et al. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42 (1993) 93-99
43. McNair D., Lorr M., and Droppleman L. Manual for the profile of mood states (1971), Educational Testing Service, San Diego (CA)
44. Ray C., Weir W., Phillips S., et al. Development of a measure of symptoms in chronic fatigue syndrome: the profile of fatigue related symptoms (PFRS). Psychol Health 7 (1992) 27-43
45. Krupp L.B., LaRocca N.G., Muir-Nash J., et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
46. Smets E.M., Garssen B., Bonke B., et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39 (1995) 315-325
47. Hays R.D., and Stewart A. Sleep measures. In: Stewart A.L., and Ware J.E. (Eds). Measuring functioning and well-being: the medical outcomes study approach (1992), Duke University Press, Durham 235-259
48. Buysse D.J., Reynolds III C.F., Monk T.H., et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193-213
49. Cesta A., Moldofsky H., and Sammut C. The sensitivity and specificity of the sleep assessment questionnaire (SAQ) as a measure of nonrestorative sleep. [abstract]. Sleep 22 (1999) 14
50. Beck A.T., Steer R.A., and Brown G.K. Manual for the Beck depression inventory-II (1996), Psychological Corporation, San Antonio (TX)
51. Radloff L.S. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
52. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
53. Beck A.T., and Steer R.A. Beck anxiety inventory: manual. 2nd edition (1990), The Psychological Corporation, Harcourt Brace Jovanovich, Inc., San Antonio
54. Spielberger C.D., Gorsuch R.L., and Lushene R. Manual for the state-trait anxiety inventory: (STAI) (Self-Evaluation Questionnaire) (1979), Consulting Psychologists Press, Palo Alto (CA)
55. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
56. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54 (1988) 1063-1070
57. Silverman S.L., and Martin S.A. Assessment tools and outcome measures used in the investigation of fibromyalgia. In: Wallace D.J., and Clauw D.J. (Eds). Fibromyalgia & other central pain syndromes (2005), Lippincott Williams & Wilkins, Philadelphia 309-319
58. Seidenberg M., Haltiner A., Taylor M.A., et al. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol 16 (1994) 93-104
59. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 (1988) 1833-1840
60. Burckhardt C.S., Clark S.R., and Bennett R.M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18 (1991) 728-733
61. Fries J.F., Spitz P., Kraines R.G., et al. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
62. Wolfe F., Hawley D.J., Goldenberg D.L., et al. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 27 (2000) 1989-1999
63. ® health survey: manual and interpretation guide (2000), QualityMetric, Inc., Lincoln (RI)
64. Reeve B.B., Burke L.B., Chiang Y.P., et al. Enhancing measurement in health outcomes research supported by agencies within the US Department of Health and Human Services. Qual Life Res 16 Suppl 1 (2007) 175-186
65. Cella D., Yount S., Rothrock N., et al. The patient-reported outcomes measurement information system (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 45 (2007) S3-11
66. Reeve B.B., Hays R.D., Bjorner J.B., et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the patient-reported outcomes measurement information system (PROMIS). Med Care 45 (2007) S22-S31
67. Fries J.F., Bruce B., and Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 23 (2005) S53-S57